NCT01466179 2017-08-18Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)Amgen Research (Munich) GmbHPhase 2 Completed225 enrolled 24 charts
NCT01471782 2017-02-08Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaAmgen Research (Munich) GmbHPhase 1/2 Completed93 enrolled 21 charts